Roche (ROG: SIX) has discontinued two Huntington’s disease programs, ending the long-running development of tominersen after ...

Amprion and Modality.AI have formed a collaboration to explore the combined use of molecular biomarkers and artificial ...

GSK (LSE: GSK) has terminated its neurodegeneration collaboration with Alector (Nasdaq: ALEC), ending an alliance established ...

Anglo-Swedish pharma major AstraZeneca has licensed ex-China rights to TQC3721, an investigational inhaled PDE3/4 inhibitor ...

The US Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for Zoryve (roflumilast) ...

India's Dr Reddy's Laboratories today revealed that supplies of its generic semaglutide would remain unavailable in India and ...

Israeli drugmaker Teva Pharmaceutical Industries has expanded its biosimilars pipeline through a global licensing agreement ...

French genetic medicines company Cyllene Therapeutics has raised 33 million euros ($38 million) in series C financing to ...

US biotech Kailera Therapeutics has reported positive top-line data from two Chinese Phase III studies of HRS-7535, an oral small-molecule GLP-1 receptor agonist it is developing outside Greater China ...

Florida, USA-based clinical-stage biopharma DemeRx has appointed Michael Snitkovsky as chief operations officer, adding a ...

French inflammatory diseases specialist Abivax yesterday announced the closing of its previously announced underwritten ...

France-based life sciences venture capital firm Sofinnova today announced that its portfolio company Myricx Bio has reached ...